Info Edge to invest in online footwear site ShoeKonnect
Info Edge to invest in online footwear site ShoeKonnect

Info Edge to invest in online footwear site ShoeKonnect

Advait Dharmadhikari Article rating: 5.0

Info Edge has invested Rs. 6 crore via its wholly-owned subsidiary in Bizcrum Infotech (ShoeKonnect). The company has acquired 60,00,000 @ 0.01 per cent Compulsorily Convertible Preference Shares having a face value of Rs. 10 each. The aggregate shareholding of the company post this investment would be 29.79 per cent on a fully converted and diluted basis.

FSL gives trendline breakout
FSL gives trendline breakout

FSL gives trendline breakout

Vinayak Gangule Article rating: 5.0

The stock of Firstsource Solutions has given downward sloping trendline breakout on Tuesday formed by connecting swing highs from December 4, 2018. The breakout was supported by justifiable volumes. Additionally, the stock formed a sizeable bullish candle on breakout day, which adds strength to the breakout.

Index trend and stocks in action April 10, 2019
Index trend and stocks in action April 10, 2019

Index trend and stocks in action April 10, 2019

Karan Dsij Article rating: 4.5

As Nifty is consolidating since last four days between 11,550 and 11,710, going ahead, a breakout from this trading range would lead to a sharper move on either side. Watch these levels closely and if it closes below or above the support and resistance levels, it will lead to explosive moves. Stocks in news: Majesco, IndusInd Bank, Vodafone Idea, Avenue Supermarts, Praj Industries, Tata Sponge Iron.

Markets may open lower amid global trade tensions and growth concerns
Markets may open lower amid global trade tensions and growth concerns

Markets may open lower amid global trade tensions and growth concerns

Karan Dsij Article rating: 5.0

Considering the early action in SGX Nifty and the Asian peers, it appears that the Indian benchmark indices are expected to open lower. Digging deeper, scaring the market participants the most is the global growth forecast from IMF as it cut global growth outlook amidst global trade tensions. Also, the US President Donald Trump threatened to impose tariffs on $11 billion worth of European Union (EU) products and the latest statement from the EU suggests these countries will retaliate. At the time of writing, SGX Nifty was trading around 11,709 levels down by 40 points.

Market rebounds, up 238 points
Market rebounds, up 238 points

Market rebounds, up 238 points

Gayathri Udyawar Article rating: 5.0

Post lunch recovery sends benchmark indices back to their highs. The BSE Sensex closed at 38,939.22, up by 238.69 points or 0.62 per cent, while Nifty50 ended the day at 11,671.95, up by 67.45 points or 0.58 per cent on Tuesday.


Overnight Digest: Stocks to look out for on April 10
Overnight Digest: Stocks to look out for on April 10

Overnight Digest: Stocks to look out for on April 10

Shohini Nath Article rating: 3.3

The stocks that are likely to witness significant movement on the bourses on April 10 are Bharat Forge, Sundram Fasteners, Tech Mahindra, GSFC and Praj Industries

GSFC to undergo maintenance shutdown
GSFC to undergo maintenance shutdown

GSFC to undergo maintenance shutdown

Amir Shaikh Article rating: 5.0

Gujarat State Fertilizers and Chemicals (GSFC) informed the bourses today that it will start annual shutdown of Ammonia - IV plant of Baroda Unit from April 13, 2019 for a period of 50 days.

Shilpa Medicare receives approval for Bortezomib for Injection
Shilpa Medicare receives approval for Bortezomib for Injection

Shilpa Medicare receives approval for Bortezomib for Injection

Advait Dharmadhikari Article rating: 4.0

Shilpa Medicare has received a tentative approval for its ANDA , Bortezomib for Injection, 3.5mg/vial from the USFDA. Bortezomib for Injection, 3.5mg/vial is a generic equivalent of reference listed drug (RLD), VELCADE used in the treatment of patients with multiple myeloma and Mantle Cell Lymphoma as recommended in the label approved by the FDA.According to IQVIA MAT Q4 2018 data, the US market for Bortezomib for Injection, 3.5mg/vial is approximately US$609 million.

Is nomination enough for estate planning?
Is nomination enough for estate planning?

Is nomination enough for estate planning?

Henil Shah Article rating: 5.0

Nomination is often considered to be the first step towards estate planning. However, just having a nomination alone is not enough for wealth distribution. Let’s find out crucial aspects of effective estate planning.

RSS
First27232724272527262728273027312732Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR